Revenue: The sum of all revenue fields included for a company's operating activities.
Lisata Therapeutics, Inc. (LSTA) had Revenue of $0.10M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$0.10M |
$-2.95M |
|
-- |
|
$0.10M |
|
$3.18M |
|
$-3.08M |
|
$0.13M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-3.08M |
|
$-3.06M |
|
8.69M |
|
8.69M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$17.70M |
|
$0.02M |
|
$0.04M |
|
$17.74M |
|
$3.07M |
|
-- |
|
$0.07M |
|
$3.14M |
|
$14.60M |
|
$14.60M |
|
$14.60M |
|
8.83M |
|
| Cash Flow Statement Financials | |
$-15.95M |
|
$15.09M |
|
$0.60M |
|
$16.21M |
|
$15.96M |
|
$-0.25M |
|
$1.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3080.00% |
|
-3080.00% |
|
-- |
|
-2954.00% |
|
-2954.00% |
|
$-15.98M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-20.23% |
|
-20.23% |
|
-16.65% |
|
-20.23% |
|
$1.65 |
|
$-1.84 |
|
$-1.84 |
|